TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

133.30

-5.99 (-4.30%)

At close: Feb 11, 2026, 4:00 PM EST

134.00

+0.70 (0.53%)

After-hours: Feb 11, 2026, 6:38 PM EST

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 28, 2019	Dec '18 Dec 29, 2018	Dec '17 Dec 30, 2017	Dec '16 Dec 31, 2016
United States Lung Revenue	14.60M	15.76M	10.55M
United States Lung Revenue Growth	-7.36%	49.36%	32.40%
United States Heart Revenue	110.58M	96.66M	59.08M
United States Heart Revenue Growth	14.40%	63.61%	97.58%
United States Liver Revenue	421.29M	309.46M	151.72M
United States Liver Revenue Growth	36.13%	103.97%	228.62%
United States OCS Transplant Revenue	546.46M	421.88M	221.35M
United States OCS Transplant Revenue Growth	29.53%	90.60%	163.39%
All Other Countries Lung Revenue	1.52M	1.93M	1.27M
All Other Countries Lung Revenue Growth	-21.24%	51.41%	44.55%
All Other Countries Heart Revenue	13.63M	13.20M	14.01M
All Other Countries Heart Revenue Growth	3.27%	-5.81%	65.80%
All Other Countries Liver Revenue	600.00K	158.00K	104.00K
All Other Countries Liver Revenue Growth	279.75%	51.92%	15.56%
All Other Countries OCS Transplant Revenue	15.75M	15.28M	15.39M
All Other Countries OCS Transplant Revenue Growth	3.04%	-0.69%	63.34%
Total OCS Transplant Revenue	562.95M	437.16M	236.74M
Total OCS Transplant Revenue Growth	28.77%	84.66%	153.30%
Other Service Revenue	-	4.38M	4.89M
Other Service Revenue Growth	-	-10.43%	-
Revenue (Total)	566.35M	441.54M	241.62M
Revenue (Total) Growth	28.27%	82.74%	158.53%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Updated Oct 29, 2025. Data Source: Fiscal.ai.